GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	65,285	166,908	168,840	222,271	553,651	1,250,928
Market Cap Growth	-60.87%	-1.14%	-24.04%	-59.85%	-55.74%	30.16%
Enterprise Value	96,508	194,585	188,532	219,584	509,945	1,241,186
Last Close Price	720.00	1959.00	2115.00	2840.00	7140.00	16200.00
PS Ratio	2.83	7.24	4.73	5.53	11.36	32.32
PB Ratio	1.60	4.08	1.97	1.99	3.05	6.06
P/TBV Ratio	1.60	4.10	1.98	2.00	3.06	6.08
EV/Sales Ratio	4.19	8.44	5.28	5.46	10.47	32.07
Debt / Equity Ratio	0.81	0.81	0.32	0.15	0.11	0.09
Net Debt / Equity Ratio	0.76	0.76	0.30	0.06	-0.14	-0.43
Net Debt / EBITDA Ratio	-1.21	-1.21	-1.01	-0.20	0.75	3.89
Net Debt / FCF Ratio	-1.88	-1.88	-1.31	-0.26	0.37	1.02
Asset Turnover	0.17	0.17	0.24	0.22	0.21	0.20
Inventory Turnover	2.56	2.56	2.97	3.23	3.10	3.17
Quick Ratio	0.07	0.07	0.24	0.77	1.66	3.36
Current Ratio	0.36	0.36	0.67	1.51	2.16	3.87
Return on Equity (ROE)	-81.98%	-81.98%	-49.25%	-53.09%	-19.67%	-10.42%
Return on Assets (ROA)	-20.35%	-20.35%	-17.79%	-16.17%	-10.61%	-8.88%
Return on Capital Employed (ROCE)	-67.30%	-67.30%	-39.50%	-37.70%	-21.30%	-12.70%
Earnings Yield	-79.42%	-31.07%	-28.75%	-34.99%	-6.89%	-1.27%
FCF Yield	-25.37%	-9.93%	-11.46%	-12.30%	-12.54%	-6.98%
Buyback Yield / Dilution	-3.77%	-3.77%	-2.17%	-0.34%	-4.37%	-22.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.